Eris Lifesciences buys remaining 30% stake in Swiss Parenterals for...
Ahmedabad: Eris Lifesciences Ltd, a speciality pharma player, has announced its intention to acquire the remaining 30% stake in its injectables subsidiary Swiss Parenterals Ltd (SPL) for ₹423.3 crore, making...
